In Brief: Breast implant litigation
This article was originally published in The Gray Sheet
Executive Summary
Breast implant litigation: Wayne County (Michigan) Circuit Judge Robert Colombo issues summary judgment March 20 dismissing silicone breast implant suits filed in Michigan against Dow Chemical, the company says. Ruling in Dow Chemical's favor, Judge Colombo accepts the company's defense that silicone breast implants were products of Dow Corning Corp., in which Dow Chemical holds a 50% equity stake, and that Dow Chemical never tested silicone products for human implantation. The ruling could impact "approximately 800 cases" filed against Dow Chemical in Michigan, the firm states. Similar rulings in 1996 dismissed Dow Chemical from all suits in New York and California related to the implants. The company currently is seeking summary judgment on silicone implant cases pending in other states...
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.